[1] Roger V L, Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation, 2011. 123(4): p. e18-e209.
[2] Yang G, Wang Y, Zeng Y, et al., Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet, 2013. 9882(9882): p. 1987-2015.
[3] Matarin M, Singleton A, Hardy J, et al., The genetics of ischaemic stroke. J Intern Med, 2010. 267(2): p. 139-55.
[4] Rothwell P M, Coull A J, Giles M F, et al., Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet, 2004. 363(9425): p. 1925-1933.
[5] Rubattu S, Giliberti R, and Volpe M, Etiology and pathophysiology of stroke as a complex trait ☆. American Journal of Hypertension, 2000. 13(10): p. 1139-1148.
[6] Rosengren A, Hawken S, Ôunpuu S, et al., Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study) : case-control study. Lancet, 2004. 364(9438): p. 953-62.
[7] Warner T D,Mitchell J A, Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. Faseb Journal Official Publication of the Federation of American Societies for Experimental Biology, 2004. 18(7): p. 790-804.
[8] Vane J,Bakhle Y, Rm, Cyclooxygenases 1 and 2. Annual Review of Pharmacology & Toxicology, 1998. 38(1): p. 97-120.
[9] Maree A O, Curtin R J, Chubb A, et al., Cyclooxygenase-1 haplotype modulates platelet response to aspirin. J Thromb Haemost, 2005. 3(10): p. 2340-5.
[10] Cipollone F, ., Prontera C, ., Pini B, ., et al., Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation, 2001. 104(8): p. 921-7.
[11] Kohsaka S, Volcik K A, Folsom A R, et al., Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G−765C polymorphism in African-Americans: The Atherosclerosis Risk in Communities Study. Atherosclerosis, 2008. 196(2): p. 926-930.
[12] Donatella C, Laura F, Gianluca T, et al., The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia. Blood Coagulation & Fibrinolysis An International Journal in Haemostasis & Thrombosis, 2006. 17(2): p. 93-6.
[13] Francesco C, Elena T, Stefano M, et al., A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. Jama the Journal of the American Medical Association, 2004. 291(18): p. 2221-8.
[14] Cao L, Zhang Z, Sun W, et al., Impacts of COX-1 gene polymorphisms on vascular outcomes in patients with ischemic stroke and treated with aspirin. Gene, 2014. 546(2): p. 172-6.
[15] Kim D H, Ahn W Y, Kim D K, et al., A Promoter polymorphism (rs17222919, -1316T/G) of ALOX5AP is associated with intracerebral hemorrhage in Korean population. Prostaglandins Leukot Essent Fatty Acids, 2011. 85(3-4): p. 115-20.
[16] Li W, Xu J, Wang X, et al., Cyclooxygenase-2 (COX-2) G-765C is a protective factor for coronary artery disease but not for ischemic stroke: a meta-analysis. Atherosclerosis, 2009. 207(2): p. 492-5.
[17] Chen G Z, Shan X Y, Cheng G P, et al., Cyclooxygenase-2 genetic polymorphism and stroke subtypes in Chinese. J Mol Neurosci, 2013. 51(2): p. 467-73.
[18] Phillips P C, The language of gene interaction. Genetics, 1998. 149(3): p. 1167-1171.
[19] Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke, 1989. 20(10): p. 1407-31.
[20] Adams H P, Bendixen B H, Kappelle L J, et al., Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993. 24(1): p. 35-41.
[21] Hu D Y, Ding R J, Interpretation of the guidlines for prevention and teatments of dyslipidemia in Chinese adults. Journal of Chinese medicine, 2010. 47(9): p. 723-724. [in Chinese]
[22] Hallstrom A P, Cobb L A, and Ray R, . Smoking as a risk factor for recurrence of sudden cardiac arrest. New England Journal of Medicine, 1986. 314(5): p. 271-5.
[23] Langaee T,Ronaghi M, Genetic variation analyses by Pyrosequencing. Mutat Res, 2005. 573(1-2): p. 96-102.
[24] Tetsuya K, Atsuro M, Hayato I, et al., Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. European Journal of Biochemistry, 1994. 221(3): p. 889-897.
[25] Calder P C, Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie, 2009. 91(6): p. 791–795.
[26] Vucević D, Radak D, Radosavljević T, et al., [Inflammatory process in atherogenesis: new facts about old flame]. Medicinski Pregled, 2012. 65(9-10): p. 388-395.
[27] Yi X Y, Zhou Q, Lin J, et al., Interaction between ALOX5AP-SG13S114A/T and COX-2-765G/C increases susceptibility to cerebral infarction in a Chinese population. Genet Mol Res, 2013. 12(2): p. 1660-9.
[28] Lemaitre R N, Rice K, Marciante K, et al., Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke. Atherosclerosis, 2009. 204(2): p. e58-63.
[29] Anika D, Sarvendra Vikram S, Charanjeet Singh S, et al., Cyclooxygenase 2 gene polymorphisms and chronic periodontitis in a North Indian population: a pilot study. Journal of Periodontal & Implant Science, 2012. 42(5): p. 151-7.
[30] Guo S, Li X, Gao M, et al., Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese. PLoS One, 2012. 7(6): p. e39814.
[31] Yafeng W, Heping J, Tianyun L, et al., Cyclooxygenase-2 -1195G>A (rs689466) polymorphism and cancer susceptibility: an updated meta-analysis involving 50,672 subjects. International Journal of Clinical & Experimental Medicine, 2015. 8(8): p. 12448-62.
[32] Chen Z Y, Li S S, li J, et al., Cyclooxygenase-2 genetic polymorphism and stroke subtypes in Chinese Han population. Journal of Chinese general medicne, 2014(17): p. 1959-1963. [in Chinese].
[33] Du D H, Wu J, Gao P, et al., Cyclooxygenase-2 genetic polymorphism and stroke. Journal of Stroke and Neurological disorders, 2008. 25(1): p. 49-52. [in Chinese]